Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial.
Claudia R L CardosoNathalie C LeiteFernanda O CarlosAndréia A LoureiroBianca B ViegasGil Fernando SallesPublished in: Diabetes care (2017)
Diacerein reduced mean HbA1c levels, with peak of effect at the 24th week of treatment. The drug was well tolerated and may be indicated as adjunct treatment in patients with type 2 diabetes, particularly in those with osteoarthritis.